Epidermal Growth Factor Receptor (EGFR)-Mediated Adverse Events (AEs) in Patients (pts) With EGFR-Mutation Positive (EGFR M+) Non-Small Cell Lung Cancer (NSCLC) Treated With Afatinib (A): Metastatic Non-Small Cell Lung Cancer.

Authors :: Wu, Y.
Geater, S.L.
Mok, T.
O'Byrne, K.J.
Schuler, M.H.
Sequist, L.V.
Yang, J.C.
Massey, D.
O’Brien, D.
Zazulina, V.
Source :: International Journal of Radiation Oncology, Biology, Physics. Nov2014 Supplement, Vol. 90 Issue 5, pS41-S41. 1p.
Publication Year :: 2014

Subjects :: *EPIDERMAL growth factor receptors
*GENETIC mutation
*LUNG cancer treatment
*METASTASIS
*PROTEIN-tyrosine kinase inhibitors
*ADVERSE health care events

Full Text Access

Tools